apply to participate in the latest Diabetic Peripheral Neuropathy Study

Now Enrolling for Diabetic Peripheral Neuropathy Studies!

We are conducting a 3-month study to evaluate the effectiveness of a medication in reducing neuropathy pain in the feet. Eligible participants may receive either the active medication or a placebo and can earn up to $2,000 in compensation. To qualify, participants must not be taking opioids, gabapentin, or Lyrica.